EU Gastrointestinal Drugs Market Segmented by Product type (Acid Neutralizers, Antidiarrheal and Laxatives, Antiemetic and Antinauseants, Biologics and Others), by Route of Administration (Oral and Parental) by Distribution Channel (Hospital Pharmacies, Online Pharmacies, Retail Pharmacies) Growth, Trends and Forecast, 2019-2028
- Published Date: 2022-12-26
- Report ID: 138259
- Pages: 200
-
Format:
Report Overview
The EU Gastrointestinal Drugs market size stood at round USD 0.12 billion in 2019 and is projected to reach USD 0.17 billion by 2028, exhibiting a CAGR of xx% during the forecast period
Gastrointestinal drugs include promotility drugs, antimotility drugs, and drugs for acid-related disorders. The generally used gastrointestinal drugs as a group are considered safe. Gastrointestinal (GI) disease affects the stomach, pancreas, rectum and large intestine, esophagus, small intestine, gallbladder, and liver. The main symptoms of gastrointestinal disorders are indigestion, heartburn, constipation bloating, and so on
Market Drivers
The rising prevalence of gastrointestinal (GI) diseases, and increase in development of biologics are the major factors expected to boost the growth of the gastrointestinal drugs market in Europe. However, the market is likely to get impacted by the risk factor such as side effects associated with the drugs during the forecast period
1. EU Gastrointestinal Drugs Market Overview
A. Market Size
2. EU Gastrointestinal Drugs Market Growth Drivers
A. Rise in Prevalence of Gastrointestinal (GI) Diseases
B. Increase in Development of Biologics
3. EU Gastrointestinal Drugs Market Segmentation
A. By Product type
I. Acid Neutralizers
II. Antidiarrheal and Laxatives
III. Anti-Inflammatory Drugs
IV. Antiemetic and Antinauseants
V. Biologics
VI. Others
B. By Route of Administration
I. Oral
II. Parental
C. By Distribution Channel
I. Hospital Pharmacies
II. Online Pharmacies
III. Retail Pharmacies
4. EU Gastrointestinal Drugs Major Market Share
A. Market Analysis, Insights and Forecast by Revenue
5. Competitive Landscape
A. Major Players
B. Products in Pipeline
6. Key Company Profiles
A. Sanofi Company overview, Product & Services, Strategies & Financials
B. Johnson & Johnson Company overview, Product & Services, Strategies & Financials
C. Glaxo Smith Kline Company overview, Product & Services, Strategies & Financials
7. Healthcare Policies and Regulatory Landscape.
A. Policy Changes and Reimbursement Scenario
8. Factors Driving Market Growth
A. Key Industry Developments
B. Mergers and Acquisitions
9. Market Opportunities and Future Trends
A. Market Opportunities
B. Future Trends
10. Conclusion
Call Us
( India toll free )
+91 835 605 0278
( US toll free )
+1 800 601 6071
Drop us an email at
sales@prudentmarkets.com
Get your pre and post sales queries resolved by our Subject matter experts.
We will assist you to customize the report to fit your research needs.
Our prime focus is to provide qualitative and accurate data.
Feel free to order a sample report before purchase.
Your personal and confidential information is safe and secured.
